Found 26 matching trials
BARDA Securing Anthrax Immunity For the Elderly
PHASE2This study is designed to assess the safety and ability of BioThrax and AV7...
Location
Johnson County Clin-Trials
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
PHASE1This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Location
Krankenhaus Nordwest
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
PHASE2Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Location
Stanford University Medical Center
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909
PHASE1This study aims to compare the safety and immunogenicity of AdCh63 AMA1 and...
Location
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Old Road, Headington
AMA1-C1/Alhydrogel + CpG 7909 for Malaria
PHASE1The purpose of this study is to test an experimental malaria vaccine in abo...
Location
University of Rochester
CPG 7909 in Patients Wih Stage IV Renal Cell Cancer
PHASE1CPG 7909 given alone to patients with renal cell cancer after their nephrec...
Location
Multiple Locations
CPG 7909 Injection in Melanoma
PHASE2To determine the safety, tolerability and effects of CPG 7909 (the study dr...
Location
Multiple Locations
High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
PHASE2The goal of this clinical research study is to learn if high-dose interleuk...
Location
University of Texas MD Anderson Cancer Center
Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma
PHASE1The purposes of this study are to describe the immune response to individua...
Location
Clinique Universitaires St-Luc
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma
PHASE1To assess the effect of CPG 7909 Injection on Cutaneous T-cell lymphoma and...
Location
Multiple Locations